Pages that link to "Q79256072"

The following pages link to Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high‐grade soft tissue sarcoma (Q79256072):

Displaying 35 items.

• Predictive factors of response to mTOR inhibitors in neuroendocrine tumours (Q26775959) (← links)
• Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers (Q26998955) (← links)
• Factors underlying sensitivity of cancers to small-molecule kinase inhibitors (Q28252845) (← links)
• Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models (Q30491274) (← links)
• Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis. (Q33648854) (← links)
• Is fibroblast growth factor receptor 4 a suitable target of cancer therapy? (Q33751398) (← links)
• FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: A meta-analysis of 2618 cases and 2305 controls (Q33829236) (← links)
• The FGFR4-G388R polymorphism promotes mitochondrial STAT3 serine phosphorylation to facilitate pituitary growth hormone cell tumorigenesis (Q34102786) (← links)
• FGFR4 profile as a prognostic marker in squamous cell carcinoma of the mouth and oropharynx (Q34505851) (← links)
• Association of CTTN polymorphisms with the risk of colorectal cancer (Q35803448) (← links)
• Involvement of MET/TWIST/APC combination or the potential role of ossification factors in pediatric high-grade osteosarcoma oncogenesis (Q35945084) (← links)
• Association of FGFR3 and FGFR4 gene polymorphisms with breast cancer in Chinese women of Heilongjiang province (Q36545379) (← links)
• A Polymorphism in the FGFR4 Gene Is Associated With Risk of Neuroblastoma and Altered Receptor Degradation. (Q36594039) (← links)
• Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis (Q36609622) (← links)
• Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis (Q36612496) (← links)
• FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients (Q36614414) (← links)
• Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression (Q36787646) (← links)
• Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients (Q37050510) (← links)
• Expression of FGFR3 and FGFR4 and clinical risk factors associated with progression-free survival in synovial sarcoma (Q37379626) (← links)
• FGFR4 polymorphic alleles modulate mitochondrial respiration: A novel target for somatostatin analog action in pituitary tumors (Q37709494) (← links)
• The cancer-associated FGFR4-G388R polymorphism enhances pancreatic insulin secretion and modifies the risk of diabetes (Q37733708) (← links)
• Review: Single nucleotide polymorphisms associated with the oncogenesis of colorectal cancer (Q37962815) (← links)
• Germline variant FGFR4  p.G388R exposes a membrane-proximal STAT3 binding site. (Q38811286) (← links)
• FGFR-4 Arg388 Enhances Prostate Cancer Progression via Extracellular Signal–Related Kinase and Serum Response Factor Signaling (Q39534119) (← links)
• FGFR4 polymorphic variants modulate phenotypic features of Cushing disease (Q42056698) (← links)
• Role of tyrosine kinases in tumor progression of the head and neck (Q46132798) (← links)
• Functional FGFR4 Gly388Arg polymorphism contributes to oral squamous cell carcinoma susceptibility (Q47110071) (← links)
• The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction. (Q49306280) (← links)
• Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models. (Q53331692) (← links)
• The Fibroblast Growth Factor Receptor-4 Arg388 Allele is Associated with Gastric Cancer Progression (Q54649699) (← links)
• Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways. (Q54675021) (← links)
• The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma (Q79329595) (← links)
• [Diagnosis and treatment of soft-tissue tumors] (Q79379802) (← links)
• The role of MMP-1 and FGFR4-R388 gene polymorphisms in pituitary adenoma (Q87901849) (← links)
• Identification of a novel oncogenic mutation of FGFR4 in gastric cancer (Q90641469) (← links)